EATON VANCE MANAGEMENT – Vertex Pharmaceuticals Incorporated Transaction History
EATON VANCE MANAGEMENT portfolio value:
$130.59M
portfolio value
EATON VANCE MANAGEMENT quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.30% | 1.33K shares | 3.87M | $289.54 | 451.02K |
| Q2 2022 | share | Increase | +1.17% | 5.18K shares | 10.71M | $281.79 | 449.69K |
| Q1 2022 | share | Increase | +14.28% | 55.55K shares | 30.58M | $260.97 | 444.50K |
| Q4 2021 | share | Decrease | -11.54% | -50.75K shares | 5.23M | $222.45 | 388.95K |
| Q3 2021 | share | Decrease | -36.28% | -250.32K shares | -59.87M | $181.39 | 439.71K |
| Q2 2021 | share | Decrease | -16.84% | -139.68K shares | -39.16M | $201.63 | 690.03K |
| Q1 2021 | share | Decrease | -3.83% | -33.01K shares | -25.6M | $214.89 | 829.71K |
| Q4 2020 | share | Increase | +4.67% | 38.46K shares | -20.4M | $236.34 | 862.73K |
| Q3 2020 | share | Decrease | -1.43% | -11.96K shares | -18.46M | $272.12 | 824.26K |
| Q2 2020 | share | Decrease | -4.93% | -43.33K shares | 33.47M | $290.31 | 836.23K |
| Q1 2020 | share | Decrease | -3.54% | -32.26K shares | 9.64M | $237.95 | 879.56K |
| Q4 2019 | share | Decrease | -14.33% | -152.56K shares | 19.31M | $218.95 | 911.83K |
| Q3 2019 | share | Increase | +23.89% | 205.26K shares | 22.78M | $169.42 | 1.06M |
| Q2 2019 | share | Decrease | -4.68% | -42.19K shares | -8.25M | $183.38 | 859.13K |
| Q1 2019 | share | Decrease | -0.61% | -5.49K shares | 15.52M | $183.95 | 901.32K |
| Q4 2018 | share | Increase | +0.65% | 5.87K shares | -23.38M | $165.71 | 906.82K |
| Q3 2018 | share | Increase | +7.55% | 63.26K shares | 31.27M | $192.74 | 900.95K |
| Q2 2018 | share | Increase | +28.63% | 186.46K shares | 36.23M | $169.96 | 837.68K |
| Q1 2018 | share | Increase | +0.41% | 2.63K shares | 8.93M | $162.98 | 651.22K |
| Q4 2017 | share | Increase | +0.17% | 1.08K shares | -1.24M | $149.86 | 648.59K |
| Q3 2017 | share | Increase | +3.77% | 23.51K shares | 18.03M | $152.04 | 647.50K |
| Q2 2017 | share | Increase | +8.40% | 48.34K shares | 17.46M | $128.87 | 623.98K |
| Q1 2017 | share | Decrease | -0.30% | -1.74K shares | 20.41M | $109.35 | 575.64K |
| Q4 2016 | share | Decrease | -31.22% | -262.09K shares | -30.67M | $73.67 | 577.39K |
| Q3 2016 | share | Decrease | -15.63% | -155.47K shares | -12.37M | $87.21 | 839.48K |
| Q2 2016 | share | Increase | +142.80% | 585.17K shares | 53.01M | $86.02 | 994.95K |
| Q1 2016 | share | Decrease | -22.31% | -117.66K shares | -33.79M | $79.49 | 409.78K |